New Infographic Highlights Growth of Presbyopia and Other Age-Related Visual Impairments and Impact on Workplace Productivity, Economy

Addressing age-related visual impairments, like presbyopia, is an increasingly important and achievable policy priority as the oldest Millennials reach middle age.

New York, NEW YORK (March 15, 2022)—The Global Coalition on Aging (GCOA) today published an infographic, Vision Health and the Future of Work: An Underrecognized Priority for Governments and Employers in the 21stCentury, highlighting the growing importance of preventing avoidable visual impairments and the cascading consequences across healthcare and the 21st century workplace should visual impairments remain unaddressed. The infographic was created in partnership with the International Agency for the Prevention of Blindness (IAPB).

Globally, 2.2 billion people are living with a vision impairment, and 1 billion of these cases were either left untreated or were entirely avoidable. As our population ages, preventable visual impairment is growing in prevalence. By 2050, the number of people over 65 will almost double, from 1 in 11 to 1 in 6 people. Presbyopia is a commonly unaddressed visual impairment that often begins around age 40, when people are in the prime of their working lives. It is estimated that 510 million people cannot see well at near distances.

“Presbyopia offers an important example of where we can be doing. more. It’s widely underrecognized, in part due to ageism, yet it affects an individual’s ability to carry out a range of near vision activities—from hobbies, to mobile phone usage, to the sorts of precision tasks required in the workplace, impacting office workers and trade workers alike, with impacts starting much earlier than most people realize,” explained Mike Hodin, CEO of the Global Coalition on Aging.

The loss of productivity from presbyopia and other visual impairments will become even more consequential as the Millennial generation, the largest global generation, reaches age 40 and more older adults continue to work past traditional retirement age.

Already an estimated one-third of workers worldwide have some form of unaddressed visual impairment in need of correction, and costs due to vision loss are expected to grow as the population ages. In 2019, the U.S. spent $168 billion on direct medical costs alone for visual impairment and loss, a figure that is expected to reach $717 billion by 2050.

The infographic calls for multiple levels of action to address avoidable age-related visual impairments through:

  • greater action by policymakers and employers to support employee vision health,
  • increased employee awareness of their own vision health and the importance of prevention, early diagnosis and care,
  • further research on the impacts of age-related visual impairments on employee productivity, participation, and quality of life.

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.